Exact Mass: 326.9944
Exact Mass Matches: 326.9944
Found 74 metabolites which its exact mass value is equals to given mass value 326.9944,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Diloxanide
Diloxanide furoate is an anti-protozoal drug used in the treatment of Entamoeba histolytica and some other protozoal infections. Although it is not currently approved for use in the United States, it was approved by a CDC study in the treatment of 4,371 cases of Entamoeba histolytica from 1977 to 1990. D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents
Aristolochic acid C
Aristolochic acid C is an aristolochic acid that is phenanthrene-1-carboxylic acid substituted by a methylenedioxy group at the 3,4 positions, by an hydroxy group at position 6, and by a nitro group at position 10. It has a role as a carcinogenic agent, a metabolite, a mutagen, a nephrotoxin and a toxin. It is a C-nitro compound, a member of aristolochic acids, an aromatic ether, a cyclic acetal, a monocarboxylic acid and an organic heterotetracyclic compound. Aristolochic acid C is a natural product found in Aristolochia kaempferi, Aristolochia kankauensis, and other organisms with data available. An aristolochic acid that is phenanthrene-1-carboxylic acid substituted by a methylenedioxy group at the 3,4 positions, by an hydroxy group at position 6, and by a nitro group at position 10. Annotation level-1 Aristolochic acid C is a derivative of Aristolochic acid. Aristolochic acid is a phospholipase A2 (PLA2) inhibitor, which disrupts cortical microtubule arrays and root growth in Arabidopsis[1].
7-Bromo-1-(1H-pyrrol-2-yl)-9H-pyrido(3,4-b)indol-6-ol
1,2-Dichloro-6,8-dihydroxy-7-propyl-9H-pyrrolo[2,1-b][1,3]benzoxazine-9-one
Bifenox free acid
CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 8453
3-chloro-4-(dimethylamino)benzenediazonium,hexafluorophosphate
ethyl 3-(2-carboxy-vinyl)-4,6-dichloro-1h-indole-2-carboxylate
3,11-Dichloro-6,11-dihydro-6-methyldibenzo[c,f][1,2]thiazepine 5,5-dioxide
(Z)-4-(4-BROMOBENZYLIDENE)-2-PHENYLOXAZOL-5(4H)-ONE
tert-butyl 3-bromo-5-fluoro-2-methylindole-1-carboxylate
1-(5-Methyl-benzo[1,2,5]thiadiazole-4-sulfonyl)-pyrrolidine-2-carboxylic acid
3-[5-(4-chloro-benzylidene)-4-oxo-2-thioxo-thiazolidin-3-yl]-propionic acid
1-NAPHTHALENAMINE, 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-, HYDROCHLORIDE, (1R,4R)-
2,5-Dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)benzenamine
4-(3-chloro-2-cyanophenoxy)benzenesulfonyl chloride
Cytidine 2,3-cyclic phosphate
Cytidine 2,3-cyclic phosphate is a cytidine nucleotide containing a pyrophosphate group esterified to C2 and C3(cyclic) of the sugar moiety. A cyclic nucleotide is any nucleotide in which the phosphate group is bonded to two of the sugars hydroxyl groups, forming a cyclical or ring structure. 2,3 cyclic CMP is a substrate for 2,3-cyclic-nucleotide 3-phosphodiesterase (EC 3.1.4.37). This enzyme (also called CNP) catalyzes the chemical reaction: nucleoside 2,3-cyclic phosphate + H2O <-> nucleoside 2-phosphate. CNP is a myelin-associated enzyme that makes up 4\\% of total CNS myelin protein, and is thought to undergo significant age-associated changes. The absence of CNP causes axonal swelling and neuronal degeneration. The biological role of cyclic 2,3 monophosphates is not clear, although it is thought to have something to do with neuronal stasis or development. [HMDB]
(1R,3R)-METHYL-1,2,3,4-TETRAHYDRO-1-(3,4-METHYLENEDIOXYPHENYL)-9H-PYRIDO[3,4-B]INDOLE-3-CARBOXYLATE
Methyl 5-chloro-N-(methoxycarbonylmethyl)-3-sulfamoylthiophene-2-carboxylate
Ammonium ((1S,3R,4R,7S)-3-bromo-1,7-dimethyl-2-oxobicyclo[2.2.1]heptan-7-yl)methanesulfonate
(R)-TERT-BUTYL (4,4-DIBROMOBUT-3-EN-2-YL)CARBAMATE
5-iodo-7-(trifluoromethyl)-1,2,3,4-tetrahydroisoquinoline
2-(2,2,2-TRIFLUOROACETYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONYL CHLORIDE
5-(4-chloro-phenylsulfamoyl)-2-hydroxy-benzoic acid
4-[4-(1-bromoethyl)-2-cyclopropylpyrimidin-5-yl]benzonitrile
5-(4-IODO-PHENYL)-2-ISOPROPYL-2H-PYRAZOL-3-YLAMINE
6-[(2-chloroquinolin-3-yl)methyl]-[1,3]thiazolo[3,2-a]pyrimidin-5-one
5-[(2-Chlorophenyl)sulfamoyl]-2-hydroxybenzoic acid
2-[(5-Chloro-1-benzothiophen-3-yl)methyl]-1H-isoindole-1,3(2H)-di one
4,5-Dihydroxydiclofenac
A monocarboxylic acid that is the 4,5-dihydroxylated metabolite of diclofenac.
6-bromo-3-[(E)-3-chloroprop-2-enyl]-2-methyl-1H-quinoline-4-thione
4-Thiazolidinone, 2-(2,6-dichlorophenyl)-3-(2-furanylmethyl)-
2-(2,6-Difluorophenyl)-3-(5-ethyl-1,3,4-thiadiazol-2-yl)thiazolidin-4-one
ethyl N-[(2Z)-2-cyano-2-{[(2,4-dichlorophenyl)amino]methylidene}acetyl]carbamate
4,5-Dioxo-4,5-dihydro-1H-pyrrolo[2,3-F]quinoline-2,7,9-tricarboxylate
[(2R,3S,4R,5R)-5-(4-amino-5-nitro-1H-imidazol-3-ium-3-yl)-3,4-dihydroxyoxolan-2-yl] dihydrogen phosphate
2,3-dichloro-4-methoxy-N-(3-methoxypropyl)benzenesulfonamide
[(E)-[5-[4-(difluoromethylsulfanyl)phenyl]furan-2-yl]methylideneamino]thiourea
2-(4-chlorophenyl)-N-[4-(difluoromethylthio)phenyl]acetamide
DILOXANIDE FUROATE
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents
ZL006
ZL006 is a potent inhibitor of nNOS/PSD-95 interaction, and inhibits NMDA receptor-mediated NO synthesis.
